Walsh R A, O'Rourke R A
J Clin Invest. 1985 May;75(5):1426-34. doi: 10.1172/JCI111844.
To assess the direct and indirect effects of the commonly used calcium entry blockers (CEB) upon the major determinants of isovolumic left ventricular relaxation, we administered equidepressant intracoronary (IC, n = 7) and equihypotensive intravenous (n = 12) dosages of diltiazem (16 +/- 3 SE micrograms/kg IC and 63 +/- 9 micrograms/kg i.v.), verapamil (10 +/- 2 and 57 +/- 5 micrograms/kg), and nifedipine (1 +/- 0.1 and 8 +/- 0.3 micrograms/kg) to preinstrumented awake dogs with normal ventricular function. The time constant of left ventricle (LV) relaxation, analyzed by two methods (T1, from the linear relation of the natural logarithm of LV pressure and time; T2, from the linear relation of LV pressure and negative high fidelity LV pressure), was significantly and equivalently prolonged by IC diltiazem (T1 + 48%, P less than 0.02), verapamil (T1 + 43%, P less than 0.001), and nifedipine (T1 + 30%, P less than 0.03). Lesser amounts of each CEB that did not affect rate of LV pressure development or extent of shortening produced no change in T1 or T2. By contrast, intravenous calcium entry blockade either produced no significant change (diltiazem and verapamil) or shortened (nifedipine T1 - 18%, P less than 0.01) LV isovolumic relaxation. However, after beta adrenergic blockade with propranolol (2 mg/kg i.v., n = 6) no change in ventricular relaxation was observed during nifedipine and the time constant was significantly prolonged by verapamil (T1 + 15%, P less than 0.05). We conclude that calcium entry blockade directly impairs normal left ventricular relaxation: This effect is closely linked to the negative inotropic properties of these drugs. The prolongation of isovolumic relaxation produced by calcium blockade is attenuated or even reversed by reflex sympathetic stimulation and favorably altered loading conditions during systemic administration.
为评估常用的钙通道阻滞剂(CEB)对左心室等容舒张主要决定因素的直接和间接影响,我们对心室功能正常的预先植入仪器的清醒犬,冠状动脉内给予等效降压剂量(n = 7)和静脉给予等效降压剂量(n = 12)的地尔硫䓬(冠状动脉内16±3 SE微克/千克和静脉内63±9微克/千克)、维拉帕米(10±2和57±5微克/千克)以及硝苯地平(1±0.1和8±0.3微克/千克)。通过两种方法分析左心室(LV)舒张的时间常数(T1,来自LV压力自然对数与时间的线性关系;T2,来自LV压力与负高保真LV压力的线性关系),冠状动脉内地尔硫䓬(T1增加48%,P<0.02)、维拉帕米(T1增加43%,P<0.001)和硝苯地平(T1增加30%,P<0.03)均显著且等效地延长了该时间常数。不影响LV压力上升速率或缩短程度的每种CEB的较少量剂量,对T1或T2无影响。相比之下,静脉内钙通道阻滞要么无显著变化(地尔硫䓬和维拉帕米),要么缩短LV等容舒张(硝苯地平T1减少18%,P<0.01)。然而,在用普萘洛尔(2毫克/千克静脉内,n = 6)进行β肾上腺素能阻滞后,硝苯地平给药期间未观察到心室舒张的变化,维拉帕米显著延长了时间常数(T1增加15%,P<0.05)。我们得出结论,钙通道阻滞直接损害正常的左心室舒张:这种作用与这些药物的负性肌力特性密切相关。钙阻滞引起的等容舒张延长在全身给药期间通过反射性交感神经刺激而减弱甚至逆转,并因负荷条件的有利改变而改变。